HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arianna Ferro Selected Research

Therapeutics

1/2021Serum levels of anti-heat shock protein 27 antibodies in patients with chronic liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arianna Ferro Research Topics

Disease

3Neoplasms (Cancer)
01/2021 - 09/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2020 - 10/2020
2Breast Neoplasms (Breast Cancer)
02/2013 - 09/2010
1Celiac Disease (Celiac Sprue)
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2021
1Liver Diseases (Liver Disease)
01/2021
1Ketosis
11/2020
1Autoimmune Diseases (Autoimmune Disease)
10/2020
1Gastroesophageal Reflux (GERD)
08/2020
1Obesity
12/2019
1Overweight
12/2019
1Leukemia
04/2013
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/2013
1Neuroblastoma
11/2007

Drug/Important Bio-Agent (IBA)

2Proteins (Proteins, Gene)FDA Link
02/2013 - 11/2007
1Glutens (Glutelin)IBA
01/2022
1HSP27 Heat-Shock ProteinsIBA
01/2021
1AntibodiesIBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Molecular Chaperones (Chaperone, Molecular)IBA
01/2021
1Vitamin DFDA LinkGeneric
11/2020
1Insulin (Novolin)FDA Link
10/2020
1Proton Pump InhibitorsIBA
08/2020
1CarbohydratesIBA
12/2019
1Phosphotransferases (Kinase)IBA
11/2014
1NucleosidesIBA
11/2014
1Pharmaceutical PreparationsIBA
11/2014
13- iodoacetylamino- 6- methoxybenzofuran- 2- yl(3,5- trimethoxyphenyl)methanoneIBA
04/2013
1Imatinib Mesylate (Gleevec)FDA Link
04/2013
1Phosphopyruvate Hydratase (Enolase)IBA
09/2010
1Monoclonal AntibodiesIBA
09/2010
1ChromatinIBA
11/2007
1Messenger RNA (mRNA)IBA
11/2007

Therapy/Procedure

1Therapeutics
01/2021